Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

AC-T regimen

View Patient Information

A regimen consisting of cyclophosphamide and doxorubicin followed by paclitaxel, used as a neoadjuvant or adjuvant treatment for breast cancer.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	AC followed by paclitaxel AC followed by paclitaxel regimen AC-T AC-Taxol regimen adriamycin cyclophosphamide-Taxol regimen doxorubicin/cyclophosphamide followed by paclitaxel

AC-T regimen

Search NCI's Drug Dictionary